{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T18:57:54Z","timestamp":1772045874607,"version":"3.50.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010621","name":"Medical University of Lublin","doi-asserted-by":"crossref","award":["DS167"],"award-info":[{"award-number":["DS167"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Localized scleroderma (LoSc) is a rare disease manifested by an inflammation and sclerosis of the skin. The latest studies focused on glycoprotein Krebs von den Lungen-6, surfactant protein-D, chemokine ligand 18 and dipeptidylpeptidase 4 as potential biomarkers of skin fibrosis in systemic scleroderma. Our study aimed to identify 6 miRNAs with elevated or decreased levels in 38 LoSc patients (31 females, 7 males) compared to healthy volunteers (HVs) and to correlate the selected miRNAs\u2019 serum levels with the severity and the clinical symptoms of LoSc and some laboratory parameters with the selected miRNAs\u2019 serum levels. The serum levels of miRNAs, i.e. miRNA-181b-5p, miRNA-223-3p, miRNA-21-5p, let 7i-5p, miRNA-29a-3p and miRNA-210-3p were significantly increased in the LoSc patients compared to the HVs. The level of let-7i increase in the female LoSc patients correlated negatively with BSA (r\u2009=\u2009\u2009\u2212\u20090.355, p\u2009=\u20090.049) and mLoSSI (r\u2009=\u2009\u2009\u2212\u20090.432, p\u2009=\u20090.015). Moreover, the female patients with inactive LoSc had significantly higher level of let-7i (2.68-fold on average) in comparison to those with active disease (p\u2009=\u20090.045). The exact role of those molecules has not been revealed in LoSc and a long-term longitudinal research is pivotal to confirm their prognostic value.<\/jats:p>","DOI":"10.1038\/s41598-020-76995-2","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T11:03:51Z","timestamp":1605783831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Circulating miRNA-181b-5p, miRNA-223-3p, miRNA-210-3p, let 7i-5p, miRNA-21-5p and miRNA-29a-3p in patients with localized scleroderma as potential biomarkers"],"prefix":"10.1038","volume":"10","author":[{"given":"Katarzyna","family":"Wolska-Gawron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Bartosi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Rusek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Kowal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Raczkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Krasowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"key":"76995_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/ddg.12724","volume":"14","author":"A Kreuter","year":"2016","unstructured":"Kreuter, A. et al. German guidelines for the diagnosis and therapy of localized scleroderma. JDDG J. der Dtsch. Dermatol. Gesellschaft 14, 199\u2013216 (2016).","journal-title":"JDDG J. der Dtsch. Dermatol. Gesellschaft"},{"key":"76995_CR2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.clindermatol.2018.04.005","volume":"36","author":"S Florez-Pollack","year":"2018","unstructured":"Florez-Pollack, S., Kunzler, E. & Jacobe, H. T. Morphea: Current concepts. Clin. Dermatol. 36, 475\u2013486 (2018).","journal-title":"Clin. Dermatol."},{"key":"76995_CR3","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/jdv.14458","volume":"31","author":"R Knobler","year":"2017","unstructured":"Knobler, R. et al. European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes. J. Eur. Acad. Dermatol. Venereol. 31, 1401\u20131424 (2017).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"76995_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/rheumatology\/kep361","volume":"49","author":"T Arkachaisri","year":"2010","unstructured":"Arkachaisri, T., Vilaiyuk, S., Torok, K. S. & Medsger, T. A. Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: A proof-of-concept study. Rheumatology (Oxford) 49, 373\u2013381 (2010).","journal-title":"Rheumatology (Oxford)"},{"key":"76995_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1684\/ejd.2017.3024","volume":"27","author":"TG Ruksha","year":"2017","unstructured":"Ruksha, T. G., Komina, A. V. & Palkina, N. V. MicroRNA in skin diseases. Eur. J. Dermatol. 27, 343\u2013352 (2017).","journal-title":"Eur. J. Dermatol."},{"key":"76995_CR6","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.biopha.2018.09.090","volume":"108","author":"G Singhvi","year":"2018","unstructured":"Singhvi, G. et al. MicroRNAs as biological regulators in skin disorders. Biomed. Pharmacother. 108, 996\u20131004 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"76995_CR7","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00403-013-1410-1","volume":"305","author":"O Babalola","year":"2013","unstructured":"Babalola, O., Mamalis, A., Lev-Tov, H. & Jagdeo, J. The role of microRNAs in skin fibrosis. Arch. Dermatol. Res. 305, 763\u2013776 (2013).","journal-title":"Arch. Dermatol. Res."},{"key":"76995_CR8","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.4103\/0366-6999.190677","volume":"129","author":"C Yang","year":"2016","unstructured":"Yang, C., Zheng, S.-D., Wu, H.-J. & Chen, S.-J. Regulatory mechanisms of the molecular pathways infibrosis induced by microRNAs. Chin. Med. J. (Engl.) 129, 2365\u20132372 (2016).","journal-title":"Chin. Med. J. (Engl.)"},{"key":"76995_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/sji.12261","volume":"81","author":"X Deng","year":"2015","unstructured":"Deng, X. et al. The role of microRNAs in autoimmune diseases with skin involvement. Scand. J. Immunol. 81, 153\u2013165 (2015).","journal-title":"Scand. J. Immunol."},{"key":"76995_CR10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jaut.2017.12.015","volume":"89","author":"E Chouri","year":"2018","unstructured":"Chouri, E. et al. Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis. J. Autoimmunol. 89, 162\u2013170 (2018).","journal-title":"J. Autoimmunol."},{"key":"76995_CR11","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.4049\/jimmunol.1200822","volume":"190","author":"K Makino","year":"2013","unstructured":"Makino, K. et al. The downregulation of microRNA let-7a contributes to the excessive expression of type I collagen in systemic and localized scleroderma. J. Immunol. 190, 3905\u20133915 (2013).","journal-title":"J. Immunol."},{"key":"76995_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00403-012-1287-4","volume":"305","author":"M Etoh","year":"2013","unstructured":"Etoh, M. et al. microRNA-7 down-regulation mediates excessive collagen expression in localized scleroderma. Arch. Dermatol. Res. 305, 9\u201315 (2013).","journal-title":"Arch. Dermatol. Res."},{"key":"76995_CR13","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1684\/ejd.2014.2384","volume":"24","author":"T Makino","year":"2014","unstructured":"Makino, T. et al. Down-regulation of microRNA-196a in the sera and involved skin of localized scleroderma patients. Eur. J. Dermatol. 24, 470\u2013476 (2014).","journal-title":"Eur. J. Dermatol."},{"key":"76995_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"Q Yan","year":"2016","unstructured":"Yan, Q., Chen, J., Li, W., Bao, C. & Fu, Q. Targeting miR-155 to treat experimental scleroderma. Sci. Rep. 6, 1\u201310 (2016).","journal-title":"Sci. Rep."},{"key":"76995_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-019-01991-0","author":"K Wolska-Gawron","year":"2019","unstructured":"Wolska-Gawron, K., Bartosi\u0144ska, J. & Krasowska, D. MicroRNA in localized scleroderma: A review of literature. Arch. Dermatol. Res. https:\/\/doi.org\/10.1007\/s00403-019-01991-0 (2019).","journal-title":"Arch. Dermatol. Res."},{"key":"76995_CR16","first-page":"1537","volume":"17","author":"B Liu","year":"2019","unstructured":"Liu, B., Guo, Z. & Gao, W. MiR-181b-5p promotes proliferation and inhibits apoptosis of hypertrophic scar fibroblasts through regulating the MEK\/ERK\/p21 pathway. Exp. Ther. Med. 17, 1537\u20131544 (2019).","journal-title":"Exp. Ther. Med."},{"key":"76995_CR17","first-page":"1","volume":"10","author":"P Kwan","year":"2015","unstructured":"Kwan, P., Ding, J. & Tredget, E. E. MicroRNA 181b regulates decorin production by dermal fibroblasts and may be a potential therapy for hypertrophic scar. PLoS ONE 10, 1\u201316 (2015).","journal-title":"PLoS ONE"},{"key":"76995_CR18","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1093\/rheumatology\/kev234","volume":"54","author":"DM Wuttge","year":"2015","unstructured":"Wuttge, D. M. et al. Specific autoantibody profiles and disease subgroups correlate with circulating micro-RNA in systemic sclerosis. Rheumatology 54, 2100\u20132107 (2015).","journal-title":"Rheumatology"},{"key":"76995_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/tan.12874","volume":"88","author":"B-S Kim","year":"2016","unstructured":"Kim, B.-S., Jung, J.-Y., Jeon, J.-Y., Kim, H.-A. & Suh, C.-H. Circulating hsa-miR-30e-5p, hsa-miR-92a-3p, and hsa-miR-223-3p may be novel biomarkers in systemic lupus erythematosus. HLA 88, 187\u2013193 (2016).","journal-title":"HLA"},{"key":"76995_CR20","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1159\/000489185","volume":"46","author":"X Liu","year":"2018","unstructured":"Liu, X., Xu, Y., Deng, Y. & Li, H. MicroRNA-223 regulates cardiac fibrosis after myocardial infarction by targeting RASA1. Cell. Physiol. Biochem. 46, 1439\u20131454 (2018).","journal-title":"Cell. Physiol. Biochem."},{"key":"76995_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.trsl.2015.10.009","volume":"169","author":"Y Morishita","year":"2016","unstructured":"Morishita, Y. et al. MicroRNA expression profiling in peritoneal fibrosis. Transl. Res. 169, 47\u201366 (2016).","journal-title":"Transl. Res."},{"key":"76995_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0153-7","volume":"50","author":"D Ye","year":"2018","unstructured":"Ye, D., Zhang, T., Lou, G. & Liu, Y. Role of miR-223 in the pathophysiology of liver diseases. Exp. Mol. Med. 50, 1\u201312 (2018).","journal-title":"Exp. Mol. Med."},{"key":"76995_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-015-0555-z","volume":"17","author":"C Castro-Villegas","year":"2015","unstructured":"Castro-Villegas, C. et al. Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNF\u03b1. Arthritis Res. Ther. 17, 1\u201315 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"76995_CR24","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/ijd.13308","volume":"55","author":"S Jafarinejad-Farsangi","year":"2016","unstructured":"Jafarinejad-Farsangi, S. et al. Inhibition of microRNA-21 induces apoptosis in dermal fibroblasts of patients with systemic sclerosis. Int. J. Dermatol. 55, 1259\u20131267 (2016).","journal-title":"Int. J. Dermatol."},{"key":"76995_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00408-018-0115-9","volume":"196","author":"G D\u00edaz-Pi\u00f1a","year":"2018","unstructured":"D\u00edaz-Pi\u00f1a, G. et al. The role of ADAR1 and ADAR2 in the regulation of miRNA-21 in idiopathic pulmonary fibrosis. Lung 196, 393\u2013400 (2018).","journal-title":"Lung"},{"key":"76995_CR26","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/jocd.12706","volume":"17","author":"L Zhong","year":"2018","unstructured":"Zhong, L. et al. Identification and integrated analysis of microRNA expression profiles in keloid. J. Cosmet. Dermatol. 17, 917\u2013924 (2018).","journal-title":"J. Cosmet. Dermatol."},{"key":"76995_CR27","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.3892\/mmr.2016.4834","volume":"13","author":"L Rong-Han","year":"2016","unstructured":"Rong-Han, L., Bin, N., Xiao-En, M., Wei-Ming, G. & Tang-Hing, J. Regulatory roles of microRNA-21 in fibrosis through interaction with diverse pathways. Mol. Med. Rep. 13, 2359\u20132366 (2016).","journal-title":"Mol. Med. Rep."},{"key":"76995_CR28","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1161\/HYPERTENSIONAHA.115.05548","volume":"66","author":"X Wang","year":"2015","unstructured":"Wang, X. et al. MicroRNA let-7i negatively regulates cardiac inflammation and fibrosis. Hypertension 66, 776\u2013785 (2015).","journal-title":"Hypertension"},{"key":"76995_CR29","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jacc.2013.09.041","volume":"63","author":"R Roncarati","year":"2014","unstructured":"Roncarati, R. et al. Circulating miR-29a, among other up-regulated microRNAs is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 63, 920\u2013927 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"76995_CR30","doi-asserted-by":"publisher","first-page":"376","DOI":"10.5114\/aoms.2019.82919","volume":"15","author":"ZM Szemraj-Rogucka","year":"2019","unstructured":"Szemraj-Rogucka, Z. M., Szemraj, J., Masiarek, K. & Majos, A. Circulating microRNAs as biomarkers for myocardial fibrosis in patients with left ventricular non-compaction cardiomyopathy. Arch. Med. Sci. 15, 376\u2013384 (2019).","journal-title":"Arch. Med. Sci."},{"key":"76995_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jdermsci.2010.11.007","volume":"61","author":"Y Kawashita","year":"2011","unstructured":"Kawashita, Y. et al. Circulating miR-29a levels in patients with scleroderma spectrum disorder. J. Dermatol. Sci. 61, 67\u201369 (2011).","journal-title":"J. Dermatol. Sci."},{"key":"76995_CR32","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3892\/br.2017.900","volume":"6","author":"D Harmanci","year":"2017","unstructured":"Harmanci, D., Erkan, E. P., Kocak, A. & Akdogan, G. G. Role of the microRNA-29 family in fibrotic skin diseases. Biomed. Rep. 6, 599\u2013604 (2017).","journal-title":"Biomed. Rep."},{"key":"76995_CR33","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1165\/rcmb.2010-0323OC","volume":"45","author":"L Cushing","year":"2011","unstructured":"Cushing, L. et al. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 45, 287\u2013294 (2011).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"76995_CR34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/ced.12734","volume":"41","author":"G-Y Zhang","year":"2016","unstructured":"Zhang, G.-Y. et al. A novel regulatory function for miR-29a in keloid fibrogenesis. Clin. Exp. Dermatol. 41, 341\u2013345 (2016).","journal-title":"Clin. Exp. Dermatol."},{"key":"76995_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0021253","volume":"6","author":"SR Oak","year":"2011","unstructured":"Oak, S. R. et al. A microRNA processing defect in rapidly progressing idiopathic pulmonary fibrosis. PLoS ONE 6, 1\u201312 (2011).","journal-title":"PLoS ONE"},{"key":"76995_CR36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1152\/ajplung.00069.2014","volume":"307","author":"V Bodempudi","year":"2014","unstructured":"Bodempudi, V. et al. miR-210 promotes IPF fibroblast proliferation in response to hypoxia. Am. J. Physiol. Lung Cell. Mol. Physiol. 307, 283\u2013294 (2014).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"76995_CR37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11845-017-1634-8","volume":"187","author":"Q Huang","year":"2018","unstructured":"Huang, Q. et al. miR-210 expression in PBMCs from patients with systemic lupus erythematosus and rheumatoid arthritis. Iran. J. Med. Sci. 187, 243\u2013249 (2018).","journal-title":"Iran. J. Med. Sci."},{"key":"76995_CR38","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.febslet.2012.03.011","volume":"586","author":"J Qi","year":"2012","unstructured":"Qi, J. et al. MicroRNA-210 negatively regulates LPS-induced production of proinflammatory cytokines by targeting NF-\u03baB1 in murine macrophages. FEBS Lett. 586, 1201\u20131207 (2012).","journal-title":"FEBS Lett."},{"key":"76995_CR39","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"76995_CR40","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gky962","volume":"47","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M., Sato, Y., Furumichi, M., Morishima, K. & Tanabe, M. New approach for understanding genome variations in KEGG. Nucleic Acids Res. 47, D590\u2013D595 (2019).","journal-title":"Nucleic Acids Res."},{"key":"76995_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"76995_CR42","unstructured":"KEEG Database. www.kegg.jp\/kegg\/kegg1.html."},{"key":"76995_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00579","author":"B Gonz\u00e1lez-Fern\u00e1ndez","year":"2017","unstructured":"Gonz\u00e1lez-Fern\u00e1ndez, B., S\u00e1nchez, D. I., Gonz\u00e1lez-Gallego, J. & Tu\u00f1\u00f3n, M. J. Sphingosine 1-phosphate signaling as a target in hepatic fibrosis therapy. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2017.00579 (2017).","journal-title":"Front. Pharmacol."},{"key":"76995_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0182329","volume":"12","author":"S Ohkura","year":"2017","unstructured":"Ohkura, S. et al. Augmented sphingosine 1 phosphate receptor-1 signaling in cardiac fibroblasts induces cardiac hypertrophy and fibrosis through angiotensin II and interleukin-6. PLoS ONE 12, 1\u201319 (2017).","journal-title":"PLoS ONE"},{"key":"76995_CR45","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1053\/j.gastro.2008.04.004","volume":"135","author":"L Miele","year":"2008","unstructured":"Miele, L. et al. The Kruppel-Like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease. Gastroenterology 135, 282\u2013291 (2008).","journal-title":"Gastroenterology"},{"key":"76995_CR46","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/S0168-8278(03)00360-X","volume":"39","author":"P St\u00e4rkel","year":"2003","unstructured":"St\u00e4rkel, P. et al. Oxidative stress, KLF6 and transforming growth factor-\u03b2 up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. J. Hepatol. 39, 538\u2013546 (2003).","journal-title":"J. Hepatol."},{"key":"76995_CR47","first-page":"299","volume":"12","author":"P Singh","year":"2020","unstructured":"Singh, P. et al. Network-based identification of signature genes KLF6 and SPOCK1 associated with oral submucous fibrosis. Mol. Clin. Oncol. 12, 299\u2013310 (2020).","journal-title":"Mol. Clin. Oncol."},{"key":"76995_CR48","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.21037\/jtd.2019.07.25","volume":"11","author":"K Isobe","year":"2019","unstructured":"Isobe, K. et al. Clinical importance of bcl-2-like 11 deletion polymorphism in idiopathic pulmonary fibrosis. J. Thorac. Dis. 11, 2981\u20132989 (2019).","journal-title":"J. Thorac. Dis."},{"key":"76995_CR49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41584-019-0324-5","volume":"16","author":"B Hinz","year":"2020","unstructured":"Hinz, B. & Lagares, D. Evasion of apoptosis by myofibroblasts: A hallmark of fibrotic diseases. Nat. Rev. Rheumatol. 16, 11\u201331 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"76995_CR50","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1172\/JCI85499","volume":"127","author":"S Stein","year":"2017","unstructured":"Stein, S. et al. Impaired SUMOylation of nuclear receptor LRH-1 promotes nonalcoholic fatty liver disease. J. Clin. Investig. 127, 583\u2013592 (2017).","journal-title":"J. Clin. Investig."},{"key":"76995_CR51","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.2353\/ajpath.2010.091117","volume":"176","author":"H Xia","year":"2010","unstructured":"Xia, H. et al. Pathologic caveolin-1 regulation of PTEN in idiopathic pulmonary fibrosis. Am. J. Pathol. 176, 2626\u20132637 (2010).","journal-title":"Am. J. Pathol."},{"key":"76995_CR52","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1038\/jid.2011.156","volume":"131","author":"SK Parapuram","year":"2011","unstructured":"Parapuram, S. K. et al. Loss of PTEN expression by dermal fibroblasts causes skin fibrosis. J. Investig. Dermatol. 131, 1996\u20132003 (2011).","journal-title":"J. Investig. Dermatol."},{"key":"76995_CR53","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1080\/1061186X.2018.1550649","volume":"27","author":"L Chen","year":"2019","unstructured":"Chen, L., Li, S. & Li, W. LOX\/LOXL in pulmonary fibrosis: Potential therapeutic targets. J. Drug Target. 27, 790\u2013796 (2019).","journal-title":"J. Drug Target."},{"key":"76995_CR54","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1242\/dmm.030114","volume":"10","author":"G Tjin","year":"2017","unstructured":"Tjin, G. et al. Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis. DMM Dis. Model. Mech. 10, 1301\u20131312 (2017).","journal-title":"DMM Dis. Model. Mech."},{"key":"76995_CR55","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1165\/rcmb.2019-0172ED","volume":"61","author":"PA Reyfman","year":"2019","unstructured":"Reyfman, P. A. & Gottardi, C. J. Idiopathic pulmonary fibrosis and lung cancer: Finding similarities within differences. Am. J. Respir. Cell Mol. Biol. 61, 667\u2013668 (2019).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"76995_CR56","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.cytogfr.2013.08.002","volume":"24","author":"JM Mu\u00f1oz-F\u00e9lix","year":"2013","unstructured":"Mu\u00f1oz-F\u00e9lix, J. M., Gonz\u00e1lez-N\u00fa\u00f1ez, M. & L\u00f3pez-Novoa, J. M. ALK1-Smad1\/5 signaling pathway in fibrosis development: Friend or foe?. Cytokine Growth Factor Rev. 24, 523\u2013537 (2013).","journal-title":"Cytokine Growth Factor Rev."},{"key":"76995_CR57","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000484604","volume":"3","author":"Z Xu","year":"2017","unstructured":"Xu, Z. & Dai, C. Ablation of FGFR2 in fibroblasts ameliorates kidney fibrosis after ischemia\/reperfusion injury in mice. Kidney Dis. 3, 160\u2013170 (2017).","journal-title":"Kidney Dis."},{"key":"76995_CR58","doi-asserted-by":"publisher","first-page":"276","DOI":"10.15252\/emmm.201606261","volume":"10","author":"HM Al-Tamari","year":"2018","unstructured":"Al-Tamari, H. M. et al. FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis. EMBO Mol. Med. 10, 276\u2013293 (2018).","journal-title":"EMBO Mol. Med."},{"key":"76995_CR59","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1038\/jid.2012.32","volume":"132","author":"M Wu","year":"2012","unstructured":"Wu, M. et al. Osteopontin in systemic sclerosis and its role in dermal fibrosis. J. Investig. Dermatol. 132, 1605\u20131614 (2012).","journal-title":"J. Investig. Dermatol."},{"key":"76995_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells8121558","volume":"8","author":"I Abdelaziz Mohamed","year":"2019","unstructured":"Abdelaziz Mohamed, I., Gadeau, A.-P., Hasan, A., Abdulrahman, N. & Mraiche, F. Osteopontin: A promising therapeutic target in cardiac fibrosis. Cells 8, 1\u201314 (2019).","journal-title":"Cells"},{"key":"76995_CR61","doi-asserted-by":"publisher","first-page":"22047","DOI":"10.18632\/oncotarget.25173","volume":"9","author":"Z Chen","year":"2018","unstructured":"Chen, Z. et al. MiR-33 promotes myocardial fibrosis by inhibiting MMP16 and stimulating p38 MAPK signaling. Oncotarget 9, 22047\u201322057 (2018).","journal-title":"Oncotarget"},{"key":"76995_CR62","first-page":"1","volume":"10","author":"L Zhuang","year":"2020","unstructured":"Zhuang, L., Vogel, M., Villiger, P. M. & Trueb, B. Dissecting the interaction of FGF8 with receptor FGFRL1. Biomolecules 10, 1\u201311 (2020).","journal-title":"Biomolecules"},{"key":"76995_CR63","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3727\/105221618X15373858350141","volume":"19","author":"R Zhang","year":"2019","unstructured":"Zhang, R. et al. Elimination of Wnt secretion from stellate cells is dispensable for zonation and development of liver fibrosis following hepatobiliary injury. Gene Expr. J. Liver Res. 19, 121\u2013136 (2019).","journal-title":"Gene Expr. J. Liver Res."},{"key":"76995_CR64","doi-asserted-by":"publisher","first-page":"6162","DOI":"10.1073\/pnas.101130898","volume":"98","author":"A Micera","year":"2001","unstructured":"Micera, A. et al. Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc. Natl. Acad. Sci. U.S.A. 98, 6162\u20136167 (2001).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"76995_CR65","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.semarthrit.2009.03.002","volume":"40","author":"MF Seidel","year":"2010","unstructured":"Seidel, M. F., Herguijuela, M., Forkert, R. & Otten, U. Nerve growth factor in rheumatic diseases. Semin. Arthritis Rheum. 40, 109\u2013126 (2010).","journal-title":"Semin. Arthritis Rheum."},{"key":"76995_CR66","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s11255-018-2025-4","volume":"51","author":"B Chen","year":"2019","unstructured":"Chen, B. The miRNA-184 drives renal fibrosis by targeting HIF1AN in vitro and in vivo. Int. Urol. Nephrol. 51, 543\u2013550 (2019).","journal-title":"Int. Urol. Nephrol."},{"key":"76995_CR67","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/bjd.17352","volume":"180","author":"II Badshah","year":"2019","unstructured":"Badshah, I. I. et al. Differential expression of secreted factors SOSTDC1 and ADAMTS8 cause profibrotic changes in linear morphoea fibroblasts. Br. J. Dermatol. 180, 1135\u20131149 (2019).","journal-title":"Br. J. Dermatol."},{"key":"76995_CR68","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3390\/toxins12080506","volume":"12","author":"TW Hung","year":"2020","unstructured":"Hung, T. W. et al. Endothelial cell-specific molecule 1 promotes endothelial to mesenchymal transition in renal Fibrosis. Toxins (Basel) 12, 506 (2020).","journal-title":"Toxins (Basel)"},{"key":"76995_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0021253","volume":"6","author":"SR Oak","year":"2011","unstructured":"Oak, S. R. et al. A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis. PLoS ONE 6, 1\u201312 (2011).","journal-title":"PLoS ONE"},{"key":"76995_CR70","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1681\/ASN.2008050492","volume":"20","author":"Z Kassiri","year":"2009","unstructured":"Kassiri, Z. et al. Loss of TIMP3 enhances interstitial nephritis and fibrosis. J. Am. Soc. Nephrol. 20, 1223\u20131235 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"76995_CR71","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1152\/ajplung.00142.2016","volume":"311","author":"NY Chen","year":"2016","unstructured":"Chen, N. Y. et al. Macrophage bone morphogenic protein receptor 2 depletion in idiopathic pulmonary fibrosis and Group III pulmonary hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 311, 238\u2013254 (2016).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"76995_CR72","first-page":"1","volume":"8","author":"J Mu","year":"2013","unstructured":"Mu, J. et al. Functional implications of microRNA-215 in TGF-\u03b21-induced phenotypic transition of mesangial cells by targeting CTNNBIP1. PLoS ONE 8, 1\u201313 (2013).","journal-title":"PLoS ONE"},{"key":"76995_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0204239","volume":"13","author":"S Holm Nielsen","year":"2018","unstructured":"Holm Nielsen, S. et al. A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease. PLoS ONE 13, 1\u201313 (2018).","journal-title":"PLoS ONE"},{"key":"76995_CR74","doi-asserted-by":"publisher","first-page":"7325","DOI":"10.18632\/oncotarget.2621","volume":"6","author":"J Wang","year":"2015","unstructured":"Wang, J. et al. microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K\/AKT pathway. Oncotarget 6, 7325\u20137338 (2015).","journal-title":"Oncotarget"},{"key":"76995_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","volume":"5","author":"X Yang","year":"2020","unstructured":"Yang, X. et al. Twist1-induced miR-199a-3p promotes liver fibrosis by suppressing caveolin-2 and activating TGF-\u03b2 pathway. Signal Transduct. Target. Ther. 5, 1\u201312 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"76995_CR76","first-page":"772","volume":"119","author":"M K\u00f6nigshoff","year":"2009","unstructured":"K\u00f6nigshoff, M. et al. WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J. Clin. Investig. 119, 772\u2013787 (2009).","journal-title":"J. Clin. Investig."},{"key":"76995_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0024145","volume":"6","author":"MB Kirschner","year":"2011","unstructured":"Kirschner, M. B. et al. Haemolysis during sample preparation alters microRNA content of plasma. PLoS ONE 6, 1\u20139 (2011).","journal-title":"PLoS ONE"},{"key":"76995_CR78","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"76995_CR79","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.05005","author":"V Agarwal","year":"2015","unstructured":"Agarwal, V., Bell, G. W., Nam, J.-W. & Bartel, D. P. Predicting effective microRNA target sites in mammalian mRNAs. Elife https:\/\/doi.org\/10.7554\/eLife.05005 (2015).","journal-title":"Elife"},{"key":"76995_CR80","doi-asserted-by":"publisher","first-page":"D146","DOI":"10.1093\/nar\/gku1104","volume":"43","author":"N Wong","year":"2015","unstructured":"Wong, N. & Wang, X. miRDB: An online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. 43, D146\u2013D152 (2015).","journal-title":"Nucleic Acids Res."},{"key":"76995_CR81","doi-asserted-by":"publisher","first-page":"D153","DOI":"10.1093\/nar\/gku1215","volume":"43","author":"IS Vlachos","year":"2015","unstructured":"Vlachos, I. S. et al. DIANA-TarBase v7.0: Indexing more than half a million experimentally supported miRNA:mRNA interactions. Nucleic Acids Res. 43, D153 (2015).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76995-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76995-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76995-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T23:28:38Z","timestamp":1670369318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76995-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,19]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["76995"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-76995-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,19]]},"assertion":[{"value":"21 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20218"}}